Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID‐19
Journal of Paediatrics and Child Health · 2024
DOI: 10.1111/jpc.16569 ↗At a glance
Journal article in Journal of Paediatrics and Child Health, 2024. Written by Tsuyoshi Jinda and 4 co-authors. Institution: Division of Infectious Diseases, Department of Pediatrics, Hyogo Prefectural Kobe Children's Hospital, Kobe, Hyogo, Japan. Major MEDLINE topics: Adenosine Monophosphate, Antiviral Agents, COVID-19 Drug Treatment. Cited 7 times so far (Crossref); 15 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Aim
Remdesivir (RDV) causes liver enzyme elevation in adults; however, the frequency of this elevation in children and the associated risk factors are largely unknown. Therefore, we aimed to examine risk factors for liver enzyme elevation in hospitalised paediatric patients who received RDV.
Methods
This was a retrospective case–control study of all patients aged
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Infectious Diseases, Department of Pediatrics, Hyogo Prefectural Kobe Children's Hospital, Kobe, Hyogo, Japan.
- Department of Pharmacy, Hyogo Prefectural Kobe Children's Hospital, Kobe, Hyogo, Japan.
ORCID profiles: Shinsuke Mizuno
Cite
APA
Jinda, T., Mizuno, S., Tatami, S., Kasai, M., & Ishida, T. (2024). Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID‐19. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16569
Vancouver
Jinda T, Mizuno S, Tatami S, Kasai M, Ishida T. Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID‐19. Journal of Paediatrics and Child Health. 2024. doi:10.1111/jpc.16569
BibTeX
@article{Jinda2024,
author = {Jinda, Tsuyoshi and Mizuno, Shinsuke and Tatami, Shunsuke and Kasai, Masashi and Ishida, Tatsuhiko},
title = {Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID‐19},
journal = {Journal of Paediatrics and Child Health},
year = {2024},
doi = {10.1111/jpc.16569}
}
EUVIMED